544210 Stock Overview
Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Emcure Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,304.90 |
52 Week High | ₹1,408.00 |
52 Week Low | ₹1,260.05 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -3.97% |
Recent News & Updates
Recent updates
Shareholder Returns
544210 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -4.6% | 2.2% | -1.0% |
1Y | n/a | 46.7% | 43.6% |
Return vs Industry: Insufficient data to determine how 544210 performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 544210 performed against the Indian Market.
Price Volatility
544210 volatility | |
---|---|
544210 Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.7% |
Market Average Movement | 6.4% |
10% most volatile stocks in IN Market | 9.7% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 544210 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 544210's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 10,852 | Satish Mehta | www.emcure.com |
Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems.
Emcure Pharmaceuticals Limited Fundamentals Summary
544210 fundamental statistics | |
---|---|
Market cap | ₹247.37b |
Earnings (TTM) | ₹4.98b |
Revenue (TTM) | ₹66.58b |
49.6x
P/E Ratio3.7x
P/S RatioIs 544210 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
544210 income statement (TTM) | |
---|---|
Revenue | ₹66.58b |
Cost of Revenue | ₹25.36b |
Gross Profit | ₹41.23b |
Other Expenses | ₹36.24b |
Earnings | ₹4.98b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 26.35 |
Gross Margin | 61.92% |
Net Profit Margin | 7.48% |
Debt/Equity Ratio | 66.9% |
How did 544210 perform over the long term?
See historical performance and comparison